BSB
VRTX icon

Bangor Savings Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Bangor Savings Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.26M Sell
4,317
-153
-3% -$78.3K 0.17% 48
2026
Q2 		$2.22M Buy
4,470
+20
+0.4% +$8.86K 0.16% 51
2026
Q1 		$1.99M Sell
4,450
-126
-3% -$58.8K 0.16% 52
2025
Q4 		$2.07M Sell
4,576
-323
-7% -$139K 0.17% 53
2025
Q3 		$1.92M Sell
4,899
-30
-0.6% -$12.5K 0.16% 60
2025
Q2 		$2.19M Sell
4,929
-406
-8% -$187K 0.2% 51
2025
Q1 		$2.59M Sell
5,335
-218
-4% -$102K 0.24% 42
2024
Q4 		$2.24M Sell
5,553
-171
-3% -$79.3K 0.21% 53
2024
Q3 		$2.66M Sell
5,724
-444
-7% -$213K 0.25% 47
2024
Q2 		$2.89M Sell
6,168
-146
-2% -$63.4K 0.29% 37
2024
Q1 		$2.64M Sell
6,314
-407
-6% -$172K 0.27% 44
2023
Q4 		$2.73M Sell
6,721
-99
-1% -$36.6K 0.3% 40
2023
Q3 		$2.37M Sell
6,820
-171
-2% -$59.8K 0.28% 45
2023
Q2 		$2.46M Buy
6,991
+49
+0.7% +$16.5K 0.28% 44
2023
Q1 		$2.19M Sell
6,942
-39
-0.6% -$11.7K 0.26% 49
2022
Q4 		$2.02M Sell
6,981
-1,057
-13% -$322K 0.24% 55
2022
Q3 		$2.33M Sell
8,038
-78
-1% -$22.4K 0.27% 49
2022
Q2 		$2.29M Sell
8,116
-202
-2% -$54.1K 0.25% 54
2022
Q1 		$2.17M Sell
8,318
-127
-2% -$30.1K 0.23% 59
2021
Q4 		$1.85M Buy
8,445
+446
+6% +$86.7K 0.18% 80
2021
Q3 		$1.45M Buy
7,999
+959
+14% +$187K 0.15% 88
2021
Q2 		$1.42M Buy
+7,040
New +$1.47M 0.16% 85

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Bangor Savings Bank's VRTX Position: Q3 2026 in Review

Bangor Savings Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 3.4% in Q3 2026, selling an estimated $78.3K and leaving 4,317 shares worth $2.26M. The position accounts for 0.17% of the portfolio, ranked #48.

Bangor Savings Bank first reported a position in VRTX in Q2 2021 and has held it in 22 quarters since. The position peaked at $2.89M in Q2 2024. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Bangor Savings Bank held 4,317 shares of Vertex Pharmaceuticals worth $2.26M as of Q3 2026.
  • Bangor Savings Bank sold 153 Vertex Pharmaceuticals shares in Q3 2026, an estimated $78.3K.
  • Vertex Pharmaceuticals made up 0.17% of Bangor Savings Bank's portfolio in Q3 2026, its #48 holding.
  • Bangor Savings Bank first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 22 quarters since.
  • Bangor Savings Bank's Vertex Pharmaceuticals position peaked at $2.89M in Q2 2024.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Bangor Savings Bank's 13F filing for Q3 2026, filed 6 Oct 2026.